Brain natriuretic peptide enhances the endothelium-independent cAMP and vasorelaxant responses of calcitonin gene-related peptide in rat aorta

Neuropeptides

Volumn 32, Issue 6, 1998, Pages 499-509

  Fiscus, R R ^a,b   Lu, L ^a   Tu, A W K ^a   Hao, H ^b   Yang, L ^b   Wang, X ^b,c  

^a and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

^b UNIVERSITY OF KENTUCKY   (United States)

^c Department of Physics   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; CALCITONIN GENE RELATED PEPTIDE; CYCLIC AMP; CYCLIC GMP; NITRIC OXIDE; PHENYLEPHRINE; PHOSPHODIESTERASE;

ANIMAL TISSUE; AORTA; ARTICLE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE FIBER; VASODILATATION;

EID: 0032435393     PISSN: 01434179     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0143-4179(98)90078-6     Document Type: Article

References (40)

1. Wimalawansa S J. Calcitonin gene-related peptide and its receptors: Molecular genetics, physiology, pathophysiology, and therapeutic potential. Endocrine Reviews 1996; 17: 533-585.
2. Brain S D, Williams T J, Tippins J R et al. Calcitonin gene-related peptide is a potent vasodilator. Nature 1985; 313: 54-56.
3. Barnes P J, Belvisi M G, Rogers D F. Modulation of neurogenic inflammation: novel approaches to inflammatory disease. TIPS 1990; 11: 185-189.
4. Lippe I T, Holzer P. Participation of endothelium-derived nitric oxide but not prostacyclin in the gastric mucosal hyperaemia due to acid back-diffusion. Br J Pharmacol 1992; 105: 708-714.
5. Joyce C D, Fiscus R R, Wang X et al. Calcitonin gene-related peptide levels are elevated in patients with sepsis. Surgery 1990; 108: 1097-1101.
6. Wang X, Jones S B, Zhou Z et al. Calcitonin gene-related peptide (CGRP) and neuropeptide Y (NPY) levels are elevated in plasma and decreased in vena cava during endotoxic shock in the rat. Circ Shock 1992; 36: 21-30.
7. Arden W A, Fiscus R R, Wang X et al. Elevations in circulating calcitonin gene-related peptide correlate with hemodynamic deterioration during endotoxic shock in pigs. Circ Shock 1994; 42: 147-153.
8. Huttemeier P C, Ritter E F, Benveniste H. Calcitonin generelated peptide mediates hypotension and tachycardia in endotoxic rats. Am J Physiol 1993; 265: H767-H769.
9. Fiscus R R. Molecular mechanisms of endothelium-mediated vasodilation. Sem Thromb Hemost 1988; Supplement 14: 12-22.
10. Thom S M, Hughes A D, Goldberg P et al. The actions of calcitonin gene related peptide and vasoactive intestinal peptide as vasodilators in man in vivo and in vitro. Br J Clin Pharmacol 1987; 24: 139-144.
11. Wang X, Han C, Fiscus R R. Calcitonin gene-related peptide (CGRP) causes endothelium-dependent cyclic AMP, cyclic GMP and vasorelaxant responses in rat abdominal aorta. Neuropeptides 1991; 20 (2): 115-124.
12. Fiscus R R, Zhou H L, Wang X et al. Calcitonin gene-related peptide (CGRP)-induced cyclic AMP, cyclic GMP and vasorelaxant responses in rat thoracic aorta are antagonized by blockers of endothelium-derived relaxant factor (EDRF). Neuropeptides 1991; 20 (2): 133-143.
13. Hao H, Fiscus R R, Wang X, Diana J N. Nω-Nitro-L-arginine inhibits vasodilations and elevations of both cyclic AMP and cyclic GMP levels in rat aorta induced by calcitonin gene-related peptide (CGRP). Neuropeptides 1994; 26: 123-131.
14. Gray D W, Marshall I. Nitric oxide synthesis inhibitors attenuate calcitonin gene-related peptide endothelium-dependent vasodilation in rat aorta. Eur J Pharmacol 1992; 212: 37-42.
15. Gray D W, Marshall I. Human alpha-calcitonin gene-related peptide stimulates adenylate cyclase and guanylate cyclase and relaxes rat thoracic aorta by releasing nitric oxide. Br J Pharmacol 1992; 107: 691-696.
16. Fiscus R R, Hao H, Wang X et al. Nitroglycerin (exogenous nitric oxide) substitutes for endothelium-derived nitric oxide in potentiating vasorelaxations and cyclic AMP elevations induced by calcitonin gene-related peptide (CGRP) in rat aorta. Neuropeptides 1994; 26: 133-144.
17. Kubota M, Moseley J M, Butera L et al. Calcitonin gene-related peptide stimulates cyclic AMP formation in rat aortic smooth muscle cells. Biochem Biophys Res Commun 1985; 132: 88-94.
18. Li Y, Fiscus R R, Wu J et al. The antiproliferative effects of calcitonin gene-related peptide in different passages of cultured vascular smooth muscle cells. Neuropeptides 1997; 31 (5): 503-509.
19. Lindgren S, Rascon A, Andersson K -E et al. Selective inhibition of cGMP-inhibited and cGMP-noninhibited cyclic nucleotide phosphodiesterase and relaxation of rat aorta. Biochemical Pharmacology 1991; 42: 545-552.
20. Maurice D H, Haslam RJ. Nitroprusside enhances isoprenaline-induced increases in cAMP in rat aortic smooth muscle. Eur J Pharmacol 1990; 191: 471-475.
21. Maurice D H, Crankshaw D, Haslam R J. Synergistic actions of nitrovasodilators and isoprenaline on rat aortic smooth muscle. Eur J Pharmacol 1991; 192: 235-242.
22. Brown G C. Nitric oxide regulates mitochondrial respiration and cell functions by inhibiting cytochrome oxidase. FEBS Lett 1995; 369: 136-139.
23. Kanagy N L, Charpie J R, Dananberg J, Webb R C. Decreased sensitivity to vasoconstrictors in aortic rings after acute exposure to nitric oxide. Am J Physiol 1996; 271: H253-H260.
24. Duhe R J, Nielsen M D, Dittman A H et al. Oxidation of critical cysteine residues of type I adenylyl cyclase by o-iodosobenzoate or nitric oxide reversibly inhibits stimulation by calcium and calmodulin. J Biol Chem 1994; 269: 7290-7296.
25. Macarthur H, Mattammal M B, Westfall T C. A new perspective on the inhibitory role of nitric oxide in sympathetic neurotransmission. Biochem Biophys Res Commun 1995; 216: 686-692.
26. Gopalakrishna R, Chen Z H, Gundimeda U. Nitric oxide and nitric oxide-generating agents induce a reversible inactivation of protein kinase C activity and phorbol ester binding. J Biol Chem 1993; 268: 27180-27185.
27. Hirata Y, Shichiri M, Emori T et al. Brain natriuretic peptide interacts with atrial natriuretic peptide receptor in cultured rat vascular smooth muscle cells. FEBS Lett 1988; 238: 415-418.
28. Song D L, Kohse K P, Murad F. Brain natriuretic factor augmentation of cellular cyclic GMP, activation of particulate guanylate cyclase and receptor binding. FEBS Lett 1988; 232 (1): 125-129.
29. Zhou H L, Fiscus R R. Brain natriuretic peptide (BNP) causes endothelium-independent relaxation and elevation of cyclic GMP in rat thoracic aorta. Neuropeptides 1989; 14: 161-169.
30. Yang L, Hao H, Wang X, Fiscus R R. Brain natriuretic peptide (BNP) and calcitonin gene-related peptide (CGRP) act synergistically to cause vasorelaxations and cAMP elevations in de-endothelialized rat aortic rings. FASEB J 1995; 9 (3): A91. (abstract)
31. Fiscus R R, Rapoport R M, Murad F. Endothelium-dependent and nitrovasodilator-induced activation of cyclic GMP-dependent protein kinase in rat aorta. J Cycl Nucl Prot Phos Res 1983; 9: 415-425.
32. Murad F, Rapoport R M, Fiscus R R. Role of cyclic GMP in relaxation of vascular smooth muscle. J Cardiovasc Pharmacol 1985; 7: S111-S118.
33. Lincoln T M. Cyclic GMP: Biochemistry, Physiology and Pathophysiology. Austin, R.G. Landes Company, 1994.
34. Fiscus R R, Rapoport R M, Waldman S A, Murad F. Atriopeptin II elevates cyclic GMP, activates cyclic-GMP-dependent protein kinase and causes relaxation in rat thoracic aorta. Biochim Biophys Acta 1985; 846: 179-184.
35. Fiscus R R, Murad F. cGMP-dependent protein kinase activation in intact tissues; in Corbin J D, Johnson R A (eds): Methods in Enzymology. Initiation and Termination of Cyclic Nucleotide Action. San Diego, California, Academic Press, Inc. 1988, pp 150-159.
36. Beavo J A, Conti M, Heaslip R J: Multiple cyclic nucleotide phosphodiesterase. Mol Pharmacol 1994; 46: 399-405.
37. Komas N, Lugnier C, Stoclet J -C: Endothelium-dependent and independent relaxation of the rat aorta by cyclic nucleotide phosphodiesterase inhibitors. Br J Pharmacol 1991; 104: 495-503.
38. Jang E K, Davidson M M L, Crankshaw D, Haslam R J. Synergistic inhibitory effects of atriopeptin II and isoproterenol on contraction of rat aortic smooth muscle: role of cGMP and cAMP. Eur J Pharmacol 1993; 250: 477-481.
39. Gross S S, Kilbourn R G, Griffith O W. NO in septic shock: good, bad or ugly? Learning from iNOS knockouts. Trends Microbiol 1996; 4: 47-49.
40. Mukoyama M, Nakao K, Hosoda K et al. Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. J Clin Invest 1991; 87: 1402-1412.